Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-27 @ 3:06 AM
Study NCT ID:
NCT00453427
Status:
COMPLETED
Last Update Posted:
2015-06-03
First Post:
2007-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Organization: